Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027300
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2001-11-30
Brief Title:
Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Sponsor:
Biogen
Organization:
Biogen
Organization Data
Organization:
Biogen
Class:
INDUSTRY
Study ID:
C-1801
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biogen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Biogen Idec Medical Director
Old Organization:
Biogen Idec
Collaborators
| Name | Class |
|---|---|
| Elan Pharmaceuticals | INDUSTRY |